Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC awarded grant for new advanced medical imaging centre
The Vaccinology and Cell Therapy Hub (pictured) will be built as part of a £45 million redevelopment of the College's Potters Bar campus.

Centre will facilitate 'world-class' research, clinical work and training

The Royal Veterinary College (RVC) has received a £2.13 million Getting Building Fund grant towards building a new Cardiovascular Imaging Centre of Excellence (C-ICE) in Hertfordshire.

The new centre – funded by the Hertfordshire Local Enterprise Partnership (LEP) – will contain modern research and development facilities to help advance treatments for both humans and animals, as well as improving training for academics, students and veterinary sector enterprises.

According to the College, C-ICE will also contain a state-of-the-art 3 Tesla MRI scanner capable of producing high-resolution images of pathological conditions for diagnostic and treatment evaluation.

The scanner will be fully integrated with the RVC’s Queen Mother Hospital for Animals and will be used initially to research novel treatments in experimental animal models of human disease and then in veterinary patients – in particular, neurological and cardiac conditions.

The RVC aims to bolster Hertfordshire's strong biopharma sector through a £45 million redevelopment of it's Potters Bar campus. This will create improved teaching facilities and a new Veterinary Vaccinology and Cell Therapy Hub.

As part of this new science hub, C-ICE will also include a cardiac catheterisation lab, which the College states will facilitate the delivery of cell and gene therapies – also known as ‘living medicines’ - into the cardiac circulation through coronary artery catheterisation.

Jonathan Elliott, vice-principal for research and innovation at the RVC, said:“I am delighted that the RVC has been awarded this grant. The establishment of this centre will not only pave the way for innovation in the field of regenerative medicine, precisely tailored to the individual patient, it will also contribute to the growth of our local economy.

“At the RVC we recognise the importance of a collaborative ‘One Health’ approach to cutting edge science which benefits both veterinary and human medicine.

“This centre will facilitate research which could transform the treatment of some of the most important debilitating chronic diseases affecting today’s ageing society.”

Image (c) Royal Veterinary College.

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.